证券代码：002157 证券简称：正邦科技 公告编号：2025—031 江西正邦科技股份有限公司 关于2025年4月份生猪销售情况简报 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 江西正邦科技股份有限公司（以下简称"公司"）的经营范围中包括生猪养殖 业务，现公司就每月生猪销售情况进行披露，具体内容如下： 一、2025年4月份生猪销售情况 | 2025年2月 | 45.07 | 102.21 | 4.63 | 11.45 | 14.35 | 131.61 | | --- | --- | --- | --- | --- | --- | --- | | 2025年3月 | 62.56 | 164.77 | 6.89 | 18.33 | 14.76 | 130.28 | | 2025年4月 | 60.98 | 225.75 | 7.38 | 25.71 | 14.44 | 132.78 | 注：以上数据如存在尾差，是因为四舍五入导致的。 二、原因说明 2025年4月，公司生猪销售数量和销售收入同比增幅较大主要是公司复工复产 工作有序推进所致。 2025年1-4月， ...

证券代码：002157 证券简称：正邦科技 公告编号：2025—032 江西正邦科技股份有限公司 关于对外担保的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、担保情况概述 （一）江西正邦科技股份有限公司（以下简称"公司"或"正邦科技"）公 司于 2024 年 12 月 11 日召开第八届董事会第四次临时会议，以 5 票同意、0 票 反对、0 票弃权，审议通过了《关于 2025 年度为子公司提供担保额度预计的议 案》《关于 2025 年度对外担保额度预计的议案》，内容包括： 1、为保证公司及控股子公司日常生产经营持续、稳健发展，同意公司为合 并报表范围内子公司提供担保，新增担保额度总计不超过 21 亿元（该预计担保 额度可循环使用）；其中本公司或控股子公司为资产负债率 70%以上的控股子公 司担保的额度为 11 亿元；为资产负债率 70%以下的控股子公司担保的额度为 10 亿元。在全年预计担保总额范围内，各下属控股子公司的担保额度可以在同类担 保对象间调剂使用。以上担保范围包括但不限于公司及下属子公司向银行、类金 融机构及财务公司等机构申请综合授 ...

Investment Rating - The investment rating for the agriculture, forestry, animal husbandry, and fishery industry is "Positive" (maintained) [2] Core Insights - The agricultural industry achieved a revenue of CNY 11,498.20 billion in 2024, a year-on-year decrease of 3.68%, while the net profit attributable to shareholders rose to CNY 466.39 billion, an increase of 806.55% [6][17] - In Q1 2025, the industry reported a revenue of CNY 2,706.77 billion, a year-on-year growth of 6.79%, with a net profit of CNY 133.13 billion, up 795.07% [6][17] - The overall profitability of the industry improved significantly in Q1 2025, with gross profit margin at 12.91%, net profit margin at 5.16%, and return on equity (ROE) at 2.57%, all showing year-on-year increases [21][30] Summary by Sections Overall Industry Performance - In 2024, the agricultural industry saw a slight decline in revenue but a substantial increase in net profit, indicating improved profitability despite lower sales [17] - The profitability metrics for Q1 2025 showed significant improvements compared to the previous year, with a notable decrease in the expense ratio [21] Sub-industry Analysis - The livestock sector experienced a remarkable increase in net profit, with pig farming turning profitable in 2024 and continuing strong performance into 2025 [6][29] - The poultry farming sector also showed strong growth, with net profit increasing significantly due to reduced feed costs and improved efficiency [43][44] - The pet food sector maintained high growth rates, with revenues and profits continuing to rise [6][25] Livestock Farming - In 2024, pig farming companies generated CNY 4,370.03 billion in revenue, a slight decline, but net profit surged to CNY 320.13 billion, reflecting a recovery in profitability [29] - In Q1 2025, revenues for pig farming increased by 18.69% year-on-year, with net profit rising by 236.12% [29][30] Poultry Farming - Poultry farming companies achieved a revenue of CNY 520.71 billion in 2024, with a net profit of CNY 28.49 billion, marking a significant increase [43] - In Q1 2025, revenue continued to grow, reaching CNY 118.71 billion, with net profit increasing to CNY 4.51 billion [43][44] Feed Industry - The feed industry reported a revenue of CNY 1,863.30 billion in 2024, with a net profit of CNY 52.48 billion, showing a significant recovery in profitability [58] - In Q1 2025, revenues rose to CNY 428.66 billion, with net profit increasing to CNY 15.26 billion [58][61] Animal Health - The animal health sector saw a revenue of CNY 129.02 billion in 2024, with a net profit of CNY 10.82 billion, despite a decline in profitability [66] - In Q1 2025, revenues increased to CNY 30.96 billion, with net profit rising to CNY 4.26 billion [66]

Industry Overview - The agricultural, forestry, animal husbandry, and fishery industry experienced a slight revenue decline in 2024, with total revenue of 1.24 trillion, down 4.06% year-on-year. However, net profit turned positive at 47.985 billion, indicating a significant improvement in profitability, particularly in the breeding sector [1][11] - In Q4 2024, the industry achieved revenue of 349.694 billion, up 0.98% year-on-year, and net profit of 16.209 billion, a substantial increase of 293.20% [1][11] - In Q1 2025, revenue reached 290.7 billion, up 4.44% year-on-year, with net profit of 13.335 billion, marking a turnaround from losses [1][11] Swine Breeding - The swine breeding sector saw a recovery in 2024, with revenue of 483.276 billion, down 2.98% year-on-year, and net profit of 33.142 billion, indicating a return to profitability [2][26] - In Q1 2025, revenue increased to 118.888 billion, up 17.32% year-on-year, with net profit of 8.151 billion, continuing the positive trend [2][26] - The sector is expected to maintain good profitability in the short term, driven by strong swine prices and improved breeding costs, while long-term trends may lead to capacity reduction and a new cycle of growth [2][26] Poultry Breeding - The poultry breeding sector achieved revenue of 72.908 billion in 2024, up 1.93% year-on-year, with net profit soaring to 2.949 billion, a remarkable increase of 2094.95% [3][10] - In Q1 2025, revenue was 16.011 billion, up 1.12% year-on-year, with net profit of 0.38 billion, up 155.38% [3][10] - The sector is closely linked to restaurant demand, and with improving downstream demand, poultry products are expected to benefit significantly [3][10] Seed Sector - The seed sector reported revenue of 24.664 billion in 2024, down 6.56%, but net profit turned positive at 0.454 billion [4][15] - In Q1 2025, revenue was 5.231 billion, up 4.79%, although net profit decreased by 31.87% [4][15] - The sector is expected to see improved demand due to ongoing agricultural revitalization efforts and increased grain yields [4][15]

Investment Rating - The report maintains a recommendation rating for the pig farming industry [5] Core Insights - The pig farming sector continues to show profitability in Q1 2025, with major companies reporting significant revenue growth [3][19] - The price of commodity pigs is expected to exhibit a weak cyclical trend, with seasonal fluctuations not being pronounced [21][23] - Under the backdrop of tariff negotiations, the weak substitute product, chlortetracycline, has significant price increase opportunities [22][25] - A strategy of selecting strong stocks during weak cycles is recommended, emphasizing cost advantages and growth potential [24] Summary by Sections Pig Farming - In Q1 2025, leading companies in the pig farming sector reported substantial revenue increases, with top performers including Zhengbang Technology, Dongrui Co., Juxing Agriculture, Muyuan Foods, and Shennong Group [3][19] - The average price of commodity pigs as of April 30, 2025, was 14.79 yuan/kg, showing a slight decrease from the previous week [21] - The report anticipates a weak cyclical trend for pig prices in 2025, influenced by production capacity and disease impacts [21][23] - Companies with cost advantages are expected to perform better in a weak cycle, while those with outdated capacities may face losses [24] Investment Recommendations - Key recommendations include Dekang Agriculture, Juxing Agriculture, Shennong Group, and Bangji Technology, with a focus on companies that possess both cost and funding advantages [4][24] - Attention is drawn to Jinhe Biology, which is expected to capitalize on price increases for chlortetracycline due to tariff changes [25] Pet Economy - The pet food sector is projected to see strong growth in 2024 and Q1 2025, with companies like Guibao Pet, Zhongchong Co., and Peidi Co. showing significant revenue increases [26][27] - The pet medical market is expanding, with a focus on the development of chain pet hospitals [28] Outdoor Sports Footwear - The sports footwear sector is experiencing steady growth, supported by domestic consumption policies [29][30] - Key brands such as Anta Sports, 361 Degrees, and Xtep International are highlighted for their performance in Q1 2025 [29]

证券研究报告 | 公司点评 gszqdatemark 2025 04 26 年 月 日 正邦科技（002157.SZ） 产能加速恢复，主业实现盈利 公司公告 2024 年度报告和 2025 年第一季度报告。2024 年公司实现收 入88.7亿元，同比增长26.86%；归母净利润2.16亿元，同比减少97.46%； 扣非归母净利润-3.33 亿元，同比增长 93.19%。2025 年第一季度公司实 现收入 30.02 亿元，同比增长 108.22%；归母净利润 1.71 亿元，同比增 长 449.58%；扣非归母净利润 0.26 亿元，同比增长 108.3%。 产能恢复主业实现盈利，负债清偿费用下降。拆分 2025 年第一季度业绩 来看，公司非经常性损益（主要为债务重组损益）贡献 1.4 亿元、减值及 资产处置影响-1.6 亿元，加回少损影响的 0.6 亿元，公司主营业务实现的 利润在 1.3 亿元，伴随产能恢复，主业已恢复盈利能力，同时公司负债率 持续下降，2025 年一季度资产负债率 44.9%，环比下降 1.5pct；财务费 用率 1.46%，较 2023 年 11.3%水平明显下降。 生猪出栏量稳步提升 ...

Group 1: Aier Eye Hospital - In 2024, Aier Eye Hospital achieved an outpatient volume of 16.94 million, a year-on-year increase of 12.14% [1] - The company reported a total revenue of 20.98 billion yuan, reflecting a growth of 3.02% compared to the previous year [2] - The net profit attributable to shareholders was 3.56 billion yuan, up by 5.87% year-on-year [2] - The company introduced several advanced medical technologies and products, including the INTENSITY™ intraocular lens and new dry eye treatment technology [1][3] Group 2: Tonghuashun - Tonghuashun reported a revenue of 4.19 billion yuan in 2024, marking a 17.47% increase from the previous year [5] - The net profit attributable to shareholders reached 1.82 billion yuan, a significant growth of 30% year-on-year [4][5] - The increase in revenue and profit was primarily driven by a recovery in the securities market and rising demand for financial information services [4] Group 3: Yiwei Lithium Energy - Yiwei Lithium Energy achieved a revenue of 1.28 billion yuan in Q1 2025, with a net profit of 110.11 million yuan, reflecting a 16.60% increase in net profit [7] - The company reported a significant increase in the shipment of energy storage batteries, with a year-on-year growth of 80.54% [8] - The company is expanding into emerging markets such as eVTOL and drones, with ongoing projects and production facilities being established [9] Group 4: Huadong Medicine - Huadong Medicine reported a revenue of 10.74 billion yuan in Q1 2025, a 3.12% increase year-on-year [10] - The net profit attributable to shareholders was 914.71 million yuan, up by 6.06% compared to the same period last year [11] - The company achieved its highest historical level of net profit excluding non-recurring gains and losses, reaching 897.34 million yuan [10] Group 5: Muyuan Foods - Muyuan Foods reported a revenue of 36.06 billion yuan in Q1 2025, a year-on-year increase of 37.26% [17] - The company turned a profit with a net profit of 44.91 billion yuan, compared to a loss of 23.79 billion yuan in the same period last year [18] - The significant growth was attributed to increased pig prices and sales [17] Group 6: China Aluminum - China Aluminum reported a revenue of 55.78 billion yuan in Q1 2025, with a net profit of 3.54 billion yuan, reflecting a year-on-year increase of 58.78% [21] - The company successfully managed market price fluctuations, resulting in increased product sales and profits [21] Group 7: Hengrui Medicine - Hengrui Medicine achieved a revenue of 72.06 billion yuan in Q1 2025, a 20.14% increase year-on-year [22] - The net profit attributable to shareholders was 18.74 billion yuan, up by 36.9% compared to the previous year [22] - The increase in profit was significantly influenced by a licensing payment received during the reporting period [22] Group 8: Bull Group - Bull Group reported a revenue of 16.83 billion yuan in 2024, reflecting a 7.24% increase year-on-year [13] - The net profit attributable to shareholders was 4.27 billion yuan, a growth of 10.39% compared to the previous year [13] - The company experienced growth in its electrical connection and smart lighting businesses, as well as rapid development in its new energy sector [14]

江西正邦科技股份有限公司 董事会关于独立董事独立性自查情况的专项意见 根据《上市公司独立董事管理办法》《深圳证券交易所股票上市规则》《深 圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》等要求， 江西正邦科技股份有限公司（以下简称"公司"）董事会，就公司在任独立董事 曹小秋、杨慧的独立性情况进行评估并出具如下专项意见： 经核查独立董事曹小秋、杨慧的任职经历以及签署的相关自查文件，上述人 员及其配偶、父母、子女等主要社会关系未在公司或公司附属企业任职，未在公 司主要股东及其附属企业任职，未与公司存在重大的持股关系，与公司以及主要 股东之间不存在重大业务往来关系或提供财务、法律、咨询、保荐等服务关系， 因此，公司独立董事符合《上市公司独立董事管理办法》《深圳证券交易所上市 公司自律监管指引第 1 号——主板上市公司规范运作》中对独立董事独立性的相 关要求。 江西正邦科技股份有限公司 董事会 二〇二五年四月二十五日 ...

江西正邦科技股份有限公司 2024 年度独立董事述职报告 各位股东及股东代表： 本人曹小秋作为江西正邦科技股份有限公司（以下简称"公司"）独立 董事，在 2024 年度严格按照《公司法》《上市公司独立董事管理办法》《上 市公司治理准则》等法律法规、规范性文件以及《公司章程》的规定和要 求，认真、勤勉、独立地履行职责，积极出席相关会议，认真审议董事会 各项议案，充分发挥了独立董事及各专门委员会委员的作用，切实维护了 公司和全体股东的利益。现将本人 2024 年度履行独立董事职责情况汇报如 下： 一、基本情况 本人曹小秋，1961年9月出生，会计学教授。1999年7月至2008年7月任南昌 大学会计系副主任、主任，2008年7月至2017年3月任南昌大学计财处处长，2017 年3月至2019年5月任南昌大学经济管理学院副院长，2019年5月至2021年12月任 南昌大学第二附属医院总会计师。现仍在南昌大学经济管理学院从事教学科研工 作。2010年至2016年任公司独立董事。2022年1月13日起再次担任公司独立董事。 报告期内，本人任职符合《上市公司独立董事管理办法》第六条规定的独立 性要求，不存在影响独立性的情 ...

证券代码：002157 证券简称：正邦科技 公告编号：2025—027 江西正邦科技股份有限公司 关于召开 2024 年年度股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 江西正邦科技股份有限公司（以下简称"公司"）第八届董事会第四次会议 审议通过了《关于召开 2024 年年度股东大会的议案》，现将本次股东大会的有 关事项通知如下： 一、会议基本情况 1、会议届次：2024 年年度股东大会。 2、会议召集人：公司董事会。 公司于 2025 年 4 月 23 日召开第八届董事会第四次会议，以 5 票同意，0 票 反对，0 票弃权，审议通过了《关于召开 2024 年年度股东大会的议案》。 3、会议召开的合法、合规性：根据公司第八届董事会第四次会议，公司将 于 2025 年 5 月 16 日召开 2024 年年度股东大会。本次股东大会的召开符合《公 司法》《上市公司股东大会规则》有关法律、行政法规、部门规章、规范性文件 和《公司章程》等规定。 4、会议召开日期和时间： 现场会议时间为：2025 年 5 月 16 日（星期五）下午 14:30。 网络投 ...